Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Assets: 2023-2025

Historic Assets for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $729.9 million.

  • CG Oncology's Assets rose 32.12% to $729.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $729.9 million, marking a year-over-year increase of 32.12%. This contributed to the annual value of $754.8 million for FY2024, which is 278.72% up from last year.
  • CG Oncology's Assets amounted to $729.9 million in Q3 2025, which was up 4.06% from $701.4 million recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Assets peaked at $754.8 million during Q4 2024, and registered a low of $199.3 million during Q4 2023.
  • Its 3-year average for Assets is $601.2 million, with a median of $640.3 million in 2024.
  • Data for CG Oncology's Assets shows a peak YoY spiked of 278.72% (in 2024) over the last 5 years.
  • CG Oncology's Assets (Quarterly) stood at $199.3 million in 2023, then soared by 278.72% to $754.8 million in 2024, then soared by 32.12% to $729.9 million in 2025.
  • Its Assets was $729.9 million in Q3 2025, compared to $701.4 million in Q2 2025 and $728.2 million in Q1 2025.